Heart Failure
Also: congestive heart failure · CHF · cardiac failure
Heart failure is a clinical syndrome of reduced cardiac output and/or congestion. Management depends on classifying severity and phenotype (reduced vs preserved ejection fraction) and optimising guideline-directed therapy.
The severity/prognosis scores, the disease-modifying drugs, and the relevant pathways are gathered here.
Calculators & scores
- MAGGIC Risk Score for Heart FailureHeart Failure
- MAGGIC Heart Failure Risk ScoreHeart Failure
- NYHA Heart Failure ClassificationHeart Failure
- HFSA Risk Score for Heart FailureHeart Failure Risk
- H2FPEF Score for HFpEFHeart Failure
- Gillmore Staging System for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)Cardiomyopathy
- Steinhart Model for Acute Heart Failure in Undifferentiated DyspnoeaHeart Failure
- Framingham Criteria for Heart FailureHeart Failure
- Killip Classification for Acute MIPrognosis
- ADHERE Algorithm for Acute Decompensated Heart FailureRisk Stratification
- ROSE Rule for SyncopeSyncope
- ACC/AHA Heart Failure StagingHeart Failure
- Framingham Heart Failure Diagnostic CriteriaHeart Failure
- Ottawa Heart Failure Risk ScaleHeart Failure
Decision pathways
Drugs
- Sacubitril-ValsartanARNI (Angiotensin Receptor-Neprilysin Inhibitor)
- Sacubitril with valsartanAngiotensin receptor-neprilysin inhibitor (ARNI)
- Spironolactone with furosemideK-sparing + loop diuretic combination
- Sacubitril/ValsartanAngiotensin Receptor-Neprilysin Inhibitor (ARNi)
- Sacubitril/Valsartan (Elderly HFrEF)ARNI — Angiotensin Receptor–Neprilysin Inhibitor
- Furosemide (IV — ICU)Loop Diuretic
- BisoprololAntihypertensive
- RamiprilAntihypertensive
- FurosemideDiuretic
- SpironolactoneDiuretic
- EplerenoneSelective Mineralocorticoid Receptor Antagonist
- DapagliflozinSGLT2 Inhibitor
Decision support only. These tools are aggregated by topic to aid navigation — always apply clinical judgement and the relevant national or local guideline.